rts logo

Recursion Pharmaceuticals Inc (RXRX): These Numbers Show Where NASDAQ:RXRX Stock Is Going Next

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) is 1.93% higher on its value in year-to-date trading and has touched a low of $4.92 and a high of $16.75 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RXRX stock was last observed hovering at around $9.48 in the last trading session, with the day’s gains setting it 0.57%.

Currently trading at $10.05, the stock is 22.55% and 7.46% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.11 million and changing 6.01% at the moment leaves the stock 11.03% off its SMA200. RXRX registered 89.98% gain for a year compared to 6-month gain of 84.07%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 29.01% loss in the last 1 month and extending the period to 3 months gives it a 2.60%, and is 14.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.79% over the week and 6.55% over the month.

Profit margin for the company is -765.90%. Distance from 52-week low is 104.27% and -39.98% from its 52-week high. The company has generated returns on investments over the last 12 months (-79.40%).

The EPS is expected to shrink by -5.93% this year.

Recursion Pharmaceuticals Inc (RXRX) Top Institutional Holders

The shares outstanding are 226.26M, and float is at 184.62M with Short Float at 21.94%.

Recursion Pharmaceuticals Inc (RXRX) Insider Activity

The most recent transaction is an insider sale by Gibson Christopher,the company’sChief Executive Officer. SEC filings show that Gibson Christopher sold 50,000 shares of the company’s common stock on May 02 ’24 at a price of $8.47 per share for a total of $0.42 million. Following the sale, the insider now owns 0.83 million shares.

Recursion Pharmaceuticals Inc disclosed in a document filed with the SEC on May 01 ’24 that Gibson Christopher (Chief Executive Officer) sold a total of 50,000 shares of the company’s common stock. The trade occurred on May 01 ’24 and was made at $7.73 per share for $0.39 million. Following the transaction, the insider now directly holds 0.86 million shares of the RXRX stock.

Still, SEC filings show that on Apr 30 ’24, Borgeson Blake (Director) disposed off 11,447 shares at an average price of $7.95 for $90964.0. The insider now directly holds 7,218,414 shares of Recursion Pharmaceuticals Inc (RXRX).

Related Posts